Skip to main content

norelgestromin and ethinyl estradiol

Generic: Norelgestromin and Ethinyl Estradiol

Verified·Apr 23, 2026
Manufacturer
Janssen
NDC
70771-1777
RxCUI
1534809
Route
TRANSDERMAL
ICD-10 indication
Z30.9

Affordability Check

How much will you actually pay for norelgestromin and ethinyl estradiol?

In 30 seconds, see every legitimate way to afford norelgestromin and ethinyl estradiol — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About norelgestromin and ethinyl estradiol

What is this medication? This medication is a combination of two hormones, a progestin called norelgestromin and an estrogen called ethinyl estradiol. It is primarily used as a form of female birth control to prevent pregnancy. Most commonly administered as a transdermal patch that is applied to the skin once a week, it works by releasing a steady flow of these hormones directly into the bloodstream through the skin.

The hormones in this medication prevent pregnancy through several different mechanisms. They primarily work by stopping the process of ovulation, which means the ovaries do not release an egg for fertilization. Additionally, the medication thickens the mucus in the cervix to make it more difficult for sperm to reach an egg and alters the lining of the uterus to prevent a fertilized egg from attaching. It is important to note that this medication does not protect against HIV or other sexually transmitted infections.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How norelgestromin and ethinyl estradiol appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-04-30).

Covered by plans

77%

4,239 of 5,509 plans

Most common tier

Tier 3

On 44% of covering formularies

Prior authorization required

0%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)67
21%
Tier 2 (generic)88
28%
Tier 3 (preferred brand)139
44%
Tier 4 (non-preferred brand)19
6%

Step therapy: 0% of formularies

Quantity limits: 32% of formularies

Coverage breadth: 313 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.